www.fdanews.com/articles/126659-regulators-clear-lotus-pharmaceuticals-asthma-drug-for-clinical-trials
Regulators Clear Lotus Pharmaceuticals Asthma Drug for Clinical Trials
April 30, 2010
Lotus Pharmaceuticals, Inc., a Chinese developer, manufacturer and seller of medicine and drugs, said that its asthma drug Laevo-Bambuterol has received
approval from China’s State Food & Drug Administration to begin clinical trials.
Benzinga
Benzinga